Cite
HARVARD Citation
Dun, M. et al. (n.d.). DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse midline glioma (NCT05009992). Neuro-oncology. pp. i18-i19. [Online].